Halozyme Therapeutics, Inc.HALONASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank57
5Y CAGR-31.3%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-31.3%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2025 | 48.02% |
| 2024 | 63.36% |
| 2023 | 26.18% |
| 2022 | -3.03% |
| 2021 | 91.26% |
| 2020 | 313.36% |
| 2019 | 2.48% |
| 2018 | -185.59% |
| 2017 | 197.35% |
| 2016 | -203.11% |